Robert Kyle, MD, of the Mayo Clinic, Rochester, MN, talks about examples of new therapies that are currently under development and investigation for the treatment of multiple myeloma (MM). Prof. Kyle puts a particular emphasis on CAR T-cell therapy, before mentioning several drugs that have been introduced and used in MM treatment over the course of the past 15 years. This interview took place at the 1st European Myeloma Network (EMN) Meeting 2018, in Turin, Italy.
